search
Back to results

Postoperative Analgesic Efficacy of Pericapsular Nerve Group Block (PENG) Block for Knee Arthroscopy

Primary Purpose

Postoperative Pain

Status
Unknown status
Phase
Not Applicable
Locations
Turkey
Study Type
Interventional
Intervention
PENG Block combinated with PCA
PCA
Sponsored by
Bora Bilal
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Postoperative Pain

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients agreed to receive PENG block
  • Knee arthroscopy

Exclusion Criteria:

  • Other kinds of knee surgery
  • Patients refuse to receive PENG block

Sites / Locations

  • KSU Faculty of Medicine Research Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Sham Comparator

Arm Label

PENG Block

CONTROL

Arm Description

PENG Block combinate with PCA

PCA

Outcomes

Primary Outcome Measures

First analgesic demand
The time interval from PENG blocks to the first analgesic demand.

Secondary Outcome Measures

Opioid consumption
Total opioid analgesic consumption
Numeric Rating Scale
The maximum score on a 10cm numeric rating scale: (0 to 10cm) (0 = no pain, 10 = worst imaginable pain)

Full Information

First Posted
February 1, 2021
Last Updated
April 13, 2021
Sponsor
Bora Bilal
search

1. Study Identification

Unique Protocol Identification Number
NCT04738500
Brief Title
Postoperative Analgesic Efficacy of Pericapsular Nerve Group Block (PENG) Block for Knee Arthroscopy
Official Title
Postoperative Analgesic Efficacy of Pericapsular Nerve Group Block (PENG) Block for Knee Arthroscopy
Study Type
Interventional

2. Study Status

Record Verification Date
April 2021
Overall Recruitment Status
Unknown status
Study Start Date
April 15, 2021 (Anticipated)
Primary Completion Date
May 30, 2021 (Anticipated)
Study Completion Date
June 15, 2021 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Bora Bilal

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Pericapsular nerve group block (PENG) has been deemed as a safe and effective regional technique for postoperative pain after knee arthroscopy.
Detailed Description
Pericapsular nerve group block(PENG) has been deemed as a safe and effective regional technique for postoperative pain after knee artroscopy. Blockade of the branches of the femoral and obturator nerves that provide innervation to any structures distal enough to be useful in knee.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Postoperative Pain

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
60 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
PENG Block
Arm Type
Active Comparator
Arm Description
PENG Block combinate with PCA
Arm Title
CONTROL
Arm Type
Sham Comparator
Arm Description
PCA
Intervention Type
Procedure
Intervention Name(s)
PENG Block combinated with PCA
Other Intervention Name(s)
PCA
Intervention Description
After spinal anesthesia PENG block will be performed
Intervention Type
Procedure
Intervention Name(s)
PCA
Intervention Description
PCA will be applied after surgery
Primary Outcome Measure Information:
Title
First analgesic demand
Description
The time interval from PENG blocks to the first analgesic demand.
Time Frame
24 Hours
Secondary Outcome Measure Information:
Title
Opioid consumption
Description
Total opioid analgesic consumption
Time Frame
24 Hours
Title
Numeric Rating Scale
Description
The maximum score on a 10cm numeric rating scale: (0 to 10cm) (0 = no pain, 10 = worst imaginable pain)
Time Frame
24 Hours

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients agreed to receive PENG block Knee arthroscopy Exclusion Criteria: Other kinds of knee surgery Patients refuse to receive PENG block
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Bora Bilal, Assos. Prof.
Phone
05052354430
Email
bilalbora@yahoo.com
Facility Information:
Facility Name
KSU Faculty of Medicine Research Hospital
City
Kahramanmaraş
ZIP/Postal Code
46200
Country
Turkey
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Bora Bilal
Phone
03443003245
Email
bbilal@ksu.edu.tr

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Postoperative Analgesic Efficacy of Pericapsular Nerve Group Block (PENG) Block for Knee Arthroscopy

We'll reach out to this number within 24 hrs